Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

A Phase II Study of Troglitazone, an Activator of the PPAR?? Receptor, in Patients with Chemotherapy-Resistant Metastatic Colorectal Cancer

Kulke, M. H., Demetri, G. D., Sharpless, N. E., Ryan, D. P., Shivdasani, R. A., Clark, J. S., Spiegelman, B. M., Kim, H. T., Mayer, R. J., & Fuchs, C. S. (2002) · The Cancer Journal · doi:10.1097/00130404-200209000-00010 · Cited by 154

Saponins as modulators of nuclear receptors

Zhang, T., Zhong, S., Li, T., & Zhang, J. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1514580 · Cited by 150

Effects of endocrine disrupting chemicals on gonad development: Mechanistic insights from fish and mammals

Delbès, G., Blázquez, M., Fernandino, J. I., Grigorova, P., Hales, B. F., Metcalfe, C. D., Navarro‐Martín, L., Parent, L., Robaire, B., Rwigemera, A., et al. (2021) · Environmental Research · doi:10.1016/j.envres.2021.112040 · Cited by 152

Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice

Girroir, E. E., Hollingshead, H. E., He, P., Zhu, B., Perdew, G. H., & Peters, J. M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.086 · Cited by 150

Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: A key to lean phenotype

Flachs, P., Rossmeisl, M., Kuda, O., & Kopecký, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.02.003 · Cited by 154

The Circadian Clock in White and Brown Adipose Tissue: Mechanistic, Endocrine, and Clinical Aspects

Froy, O., & Garaulet, M. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00193 · Cited by 155

Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism

Kersten, S. (2007) · PPAR Research · doi:10.1155/2008/132960 · Cited by 149

Peroxisome-proliferator-activated receptor-α (PPARα) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin

Sugden, M. C., Bulmer, K., Gibbons, G. F., Knight, B. L., & Holness, M. J. (2002) · Biochemical Journal · doi:10.1042/bj20011699 · Cited by 152

Excess of free fatty acids as a cause of metabolic dysfunction in skeletal muscle

TUMOVA, J., ANDEL, M., & TRNKA, J. (2016) · Physiological Research · doi:10.33549/physiolres.932993 · Cited by 143

ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis

Jao, T., Nangaku, M., Wu, C.-H., Sugahara, M., Saito, H., Maekawa, H., Ishimoto, Y., Aoe, M., Inoue, T., Tanaka, T., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.09.023 · Cited by 148

Insect chitin synthase

Tellam, R. L., Vuocolo, T., Johnson, S. E., Jarmey, J. M., & Pearson, R. D. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01679.x · Cited by 147

Heart Metabolic Disturbances in Cardiovascular Diseases

Carvajal, K., & Moreno‐Sánchez, R. (2003) · Archives of Medical Research · doi:10.1016/s0188-4409(03)00004-3 · Cited by 146

Regulation of Stearoyl-CoA Desaturase Genes: Role in Cellular Metabolism and Preadipocyte Differentiation

Kim, Y., & Ntambi, J. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1704 · Cited by 146

PPAR expression and function during vertebrate development

Michalik, L., Desvergne, B., Dreyer, C., Gavillet, M., Laurini, R., & Wahli, W. (2002) · The International Journal of Developmental Biology · doi:10.1387/ijdb.11902671 · Cited by 152

Peroxisome proliferation as a biomarker in environmental pollution assessment

Cajaraville, M. P., Cancio, I., Ibabe, A., & Orbea, A. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10329 · Cited by 148

Rat Preputial Sebocyte Differentiation Involves Peroxisome Proliferator-Activated Receptors11Preliminary reports were presented at IV International Dermatology Symposium, April 11 1997, Berlin; Biomedicine ‘97, April 25 1997, Washington, DC; and The Midwest Society for Pediatric Research, Chicago, September 25 1997.

Rosenfield, R. L., Kentsis, A., Deplewski, D., & Ciletti, N. A. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00487.x · Cited by 145

Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure

Portilla, D., Dai, G., McClure, T., Bates, L. M., Kurten, R. C., Megyesi, J. K., Price, P. M., & Li, S. (2002) · Kidney International · doi:10.1111/j.1523-1755.2002.kid553.x · Cited by 149

Genome-wide analysis of PPARα activation in murine small intestine

Bünger, M., den Bosch, H. D. V.-V., van der Meijde, J., Kersten, S., Hooiveld, G. J. E. J., & Müller, M. M. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00198.2006 · Cited by 145

Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) α and δ and PPAR coactivator 1α in human skeletal muscle, but not lipid regulatory genes

Watt, M. J., Southgate, R. J., Holmes, A. G., & Febbraio, M. A. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01499 · Cited by 143

PPARδ Agonism Activates Fatty Acid Oxidation via PGC-1α but Does Not Increase Mitochondrial Gene Expression and Function

Kleiner, S., Nguyen-Tran, V., Baré, O., Huang, X., Spiegelman, B., & Wu, Z. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008797 · Cited by 143

Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease

Fougerat, A., Montagner, A., Loiseau, N., Guillou, H., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071638 · Cited by 150

Effects of peroxisome proliferators on the thymus and spleen of mice

Yang, Q., Xie, Y., & DePierre, J. W. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01367.x · Cited by 144

Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population

Sanchez, J. G., Rios, M. S., Pérez, C. F., Laakso, M., & Larrad, M. T. M. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470495 · Cited by 143

Regulatory potential ofn-3 fatty acids in immunological and inflammatory processes

Grimm, H., Mayer, K., Mayser, P. A., & EIGENBRODT, E. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2001457 · Cited by 143

Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

Lefebvre, A., Peinado‐Onsurbe, J., Leitersdorf, I., Briggs, M. R., Paterniti, J. R., Fruchart, J., Fiévet, C., Auwerx, J. H., & Staels, B. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1756 · Cited by 143

From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets

Pistis, M., & Melis, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980014 · Cited by 145

Disturbances in the normal regulation of SREBP-sensitive genes in PPARα-deficient mice

Patel, D. D., Knight, B. L., Wiggins, D. K., Humphreys, S. M., & Gibbons, G. F. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31655-2 · Cited by 142

Peroxisome proliferator–activated receptor α in the human breast cancer cell lines MCF‐7 and MDA‐MB‐231

Suchanek, K. M., May, F. J., Robinson, J. A., Lee, W. J., Holman, N. A., Monteith, G. R., & Roberts‐Thomson, S. J. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10061 · Cited by 140

Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity

Régnier, M., Polizzi, A., Smati, S., Lukowicz, C., Fougerat, A., Lippi, Y., Fouché, E., Lasserre, F., Naylies, C., Bétoulières, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63579-3 · Cited by 151

Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor δ-Selective Agonists in Vitro and in Vivo

Iwashita, A., Muramatsu, Y., Yamazaki, T., Muramoto, M., Kita, Y., Yamazaki, S., Mihara, K., Moriguchi, A., & Matsuoka, N. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.115758 · Cited by 140

Eicosapentaenoic Acid Induces mRNA Expression of Peroxisome Proliferator‐Activated Receptor γ

Chambrier, C., Bastard, J., Rieusset, J., Chevillotte, E., Bonnefont‐Rousselot, D., Thérond, P., Hainque, B., Riou, J. P., Laville, M., & Vidal, H. (2002) · Obesity Research · doi:10.1038/oby.2002.70 · Cited by 139

Fatty Acids Rapidly Induce the Carnitine Palmitoyltransferase I Gene in the Pancreatic β-Cell Line INS-1

Assimacopoulos‐Jeannet, F., Thumelin, S., Roche, E., Esser, V., McGarry, J., & Prentki, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1659 · Cited by 136

Mulberry Anthocyanins Inhibit Oleic Acid Induced Lipid Accumulation by Reduction of Lipogenesis and Promotion of Hepatic Lipid Clearance

Chang, J.-J., Hsu, M.-J., Huang, H., Chung, D.-J., Chang, Y., & Wang, C. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf401171k · Cited by 139

PPARγ activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes

Martin, G., Schoonjans, K., Staels, B., & Auwerx, J. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00315-8 · Cited by 138

Peroxisome proliferator-activated receptor-β signaling contributes to enhanced proliferation of hepatic stellate cells

Hellemans, K., Michalik, L., Dittie, A., Knorr, A., Rombouts, K., de Jong, J., Heirman, C., Quartier, E., Schuit, F., Wahli, W., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50015 · Cited by 137

Peroxisome Proliferator-Activated Receptors (PPARs) and the Human Skin

Sertznig, P., Seifert, M., Tilgen, W., & Reichrath, J. (2008) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200809010-00002 · Cited by 135

Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model

Carta, A. R., Frau, L., Pisanu, A., Wardas, J., Spiga, S., & Carboni, E. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.046 · Cited by 137

Identification of Nuclear Receptor Corepressor as a Peroxisome Proliferator-activated Receptor α Interacting Protein

Dowell, P., Ishmael, J. E., Avram, D., Peterson, V. J., Nevrivy, D. J., & Leid, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15901 · Cited by 139

Diabetes medications and body weight

Mitri, J., & Hamdy, O. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903081725 · Cited by 134

Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic β-cell function

Fatehi‐Hassanabad, Z., & Chan, C. B. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-1 · Cited by 137

Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells

Wang, X., & Kilgore, M. W. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00154-5 · Cited by 134

Evidence for the Presence of Peroxisome Proliferator-activated Receptor (PPAR) α and γ and Retinoid Z Receptor in Cartilage

Bordji, K., Grillasca, J., Gouze, J.-N., Magdalou, J., Schohn, H., Keller, J., Bianchi, A., Dauça, M., Netter, P., & Terlain, B. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12243 · Cited by 134

Activation of Peroxisome Proliferator-Activated Receptors in Human Airway Smooth Muscle Cells Has a Superior Anti-inflammatory Profile to Corticosteroids: Relevance for Chronic Obstructive Pulmonary Disease Therapy

Patel, H. J., Belvisi, M. G., Bishop‐Bailey, D., Yacoub, M. H., & Mitchell, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2663 · Cited by 133

The Role of PPARs in Lung Fibrosis

Lakatos, H. F., Thatcher, T. H., Kottmann, R. M., Garcia, T. M., Phipps, R. P., & Sime, P. J. (2007) · PPAR Research · doi:10.1155/2007/71323 · Cited by 133

The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation

Iannotti, F. A., & Vitale, R. M. (2021) · Cells · doi:10.3390/cells10030586 · Cited by 130

Regulation of Gene Expression by Activation of the Peroxisome Proliferator-Activated Receptor γ with Rosiglitazone (BRL 49653) in Human Adipocytes

Rieusset, J., Auwerx, J. H., & Vidal, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1657 · Cited by 132

Involvement of the Peroxisome Proliferator-Activated Receptor Alpha in the Immunomodulation Caused by Peroxisome Proliferators in Mice

Yang, Q., Xie, Y., Alexson, S. E. H., Dean Nelson, B., & DePierre, J. W. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00923-1 · Cited by 131

Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics

Wilmes, A., Bielow, C., Ranninger, C., Bellwon, P., Aschauer, L., Limonciel, A., Chassaigne, H., Kristl, T., Aiche, S., Huber, C. G., et al. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.10.006 · Cited by 131

Peroxisome proliferator-activated receptor γ in malignant diseases

WANG, T., Xu, J., Yu, X., Yang, R., & Han, Z. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.08.011 · Cited by 130

Sex Difference in Hepatic Peroxisome Proliferator-Activated Receptor α Expression: Influence of Pituitary and Gonadal Hormones

Jalouli, M., Carlsson, L., Améen, C., Lindén, D., Ljungberg, A., Michalik, L., Edén, S., Wahli, W., & Oscarsson, J. (2002) · Endocrinology · doi:10.1210/en.2002-220630 · Cited by 131

Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease

Robinson, E., & Grieve, D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.003 · Cited by 132

Nutrigenomics: The Impact of Biomics Technology on Nutrition Research

Corthesy-Theulaz, I. E., den Dunnen, J. T., Ferré, P., Geurts, J. M. W., Müller, M. M., van Belzen, N., & van Ommen, B. (2005) · Annals of Nutrition and Metabolism · doi:10.1159/000088315 · Cited by 130

Peroxisome Proliferator-activated Receptor β Regulates Acyl-CoA Synthetase 2 in Reaggregated Rat Brain Cell Cultures

Modak, S. B., Braissant, O., Escher, P., Desvergne, B., Honegger, P., & Wahli, W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35881 · Cited by 130

Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation

Belvisi, M. G., Hele, D. J., & Birrell, M. A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.048 · Cited by 130

Kidney Tumor Biomarkers Revealed by Simultaneous Multiple Matrix Metabolomics Analysis

Ganti, S. N., Taylor, S. L., Aboud, O. A., Yang, J. C., Evans, C. P., Osier, M. V., Alexander, D. C., Kim, K., & Weiss, R. H. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3105 · Cited by 126

Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons

Cimini, A., Benedetti, E., Cristiano, L., Sebastiani, P., D’Amico, M. A., D’Angelo, B., & Loreto, S. D. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.043 · Cited by 129

Structure and physiological functions of the human peroxisome proliferator-activated receptor γ

Zieleniak, A., Wójcik, M., & Woźniak, L. A. (2008) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-008-0037-y · Cited by 136

Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese–diabetic mice

Goto, T., Teraminami, A., Lee, J.-Y., Ohyama, K., Funakoshi, K., Kim, Y.-I., Hirai, S., Uemura, T., Yu, R., Takahashi, N., et al. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.04.001 · Cited by 130

Peroxisome Proliferator-activated Receptor γ Activation Can Regulate β-Catenin Levels via a Proteasome-mediated and Adenomatous Polyposis Coli-independent Pathway

Sharma, C., Pradeep, A., Wong, L., Rana, A., & Rana, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403143200 · Cited by 130

Peroxisome proliferator-activated receptors in cutaneous biology

Kuenzli, S., & Saurat, J. ‐. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05532.x · Cited by 128

PPARs and other nuclear receptors in inflammation

RIZZO, G., & Fiorucci, S. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.03.012 · Cited by 128

In Vivo Actions of Peroxisome Proliferator–Activated Receptors

Eldor, R., DeFronzo, R. A., & Abdul‐Ghani, M. A. (2013) · Diabetes Care · doi:10.2337/dcs13-2003 · Cited by 128

Nuclear Factor-κB Activation Leads to Down-regulation of Fatty Acid Oxidation during Cardiac Hypertrophy

Planavila, A., Laguna, J. C., & Vázquez‐Carrera, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414220200 · Cited by 127

Prostacyclin-dependent Apoptosis Mediated by PPARδ

Hatae, T., Wada, M., Yokoyama, C., Shimonishi, M., & Tanabe, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107180200 · Cited by 126

PPARα activators and fasting induce the expression of adipose differentiation-related protein in liver

Dalen, K. T., Ulven, S. M., Arntsen, B. M., Solaas, K., & Nebb, H. I. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500459-jlr200 · Cited by 129

PPAR∞ AND GLUCOSE HOMEOSTASIS

Auwerx, J. H. (2002) · Cited by 127

Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes.

Mori, M., Ghyselinck, N. B., Chambon, P., & Mark, M. P. (2001) · PubMed · Cited by 125

Connexins 40 and 43 are differentially regulated within the kidneys of rats with renovascular hypertension

Haefliger, J., Demotz, S., Braissant, O., Suter, E., Waeber, B., NICOD, P. H., & Meda, P. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00786.x · Cited by 125

Protective effects of a peroxisome proliferator-activated receptor-β/δ agonist in experimental autoimmune encephalomyelitis

Polak, P. E., Kalinin, S., Russo, C. D., Gavrilyuk, V., Sharp, A. J., Peters, J. M., Richardson, J. C., Willson, T. M., Weinberg, G. L., & Feinstein, D. L. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.006 · Cited by 125

Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice

Edvardsson, U., Bergström, M. F., Alexandersson, M., Bamberg, K., Ljung, B., & Dahllöf, B. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33479-9 · Cited by 124

Regulation of apo A-I gene expression by fibrates

Staels, B., & Auwerx, J. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00313-4 · Cited by 124

Impact and Therapeutic Potential of PPARs in Alzheimers Disease

Heneka, M. T., Reyes-Irisarri, E., Hull, M. J., & Kummer, M. P. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376325 · Cited by 124

Oxidative Stress in the Thyroid Gland: From Harmlessness to Hazard Depending on the Iodine Content

Poncin, S., Gérard, A.-C., Boucquey, M., Sènou, M., Calderón, P. B., Knoops, B., Lengelé, B., Many, M., & Colin, I. M. (2007) · Endocrinology · doi:10.1210/en.2007-0951 · Cited by 124

Bezafibrate Reduces mRNA Levels of Adipocyte Markers and Increases Fatty Acid Oxidation in Primary Culture of Adipocytes

Cabrero, À., Alegret, M., Sánchez, R. M., Adzet, T., Laguna, J. C., & Vázquez‐Carrera, M. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1883 · Cited by 124

Peroxisome Proliferator–Activated Receptors: A Critical Link among Fatty Acids, Gene Expression and Carcinogenesis

Heuvel, J. P. V. (1999) · Journal of Nutrition · doi:10.1093/jn/129.2.575s · Cited by 126

Role of PPARγ in Regulating Adipocyte Differentiation and Insulin‐Responsive Glucose Uptake

HAMM, J. K., EL JACK, A. K., PILCH, P. F., & FARMER, S. R. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07792.x · Cited by 123

PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation

Zolezzi, J. M., Santos, M. J., Candia, S. B., Pinto, C., Godoy, J. A., & Inestrosa, N. C. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12320 · Cited by 123

Bi-directional drug-microbiome interactions of anti-diabetics

Whang, A., Nagpal, R., & Yadav, H. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.046 · Cited by 122

Mechanisms of Androgen Induction of Sebocyte Differentiation

Rosenfield, R. L., Deplewski, D., Kentsis, A., & Ciletti, N. (1998) · Dermatology · doi:10.1159/000017864 · Cited by 156

Trace Elements, PPARs, and Metabolic Syndrome

Shi, Y., Zou, Y., Shen, Z., Xiong, Y., Zhang, W., Liu, C., & Chen, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072612 · Cited by 121

Present concepts and future outlook: Function of peroxisome proliferator‐activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer

Sertznig, P., Seifert, M., Tilgen, W., & Reichrath, J. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20998 · Cited by 119

Human B Lymphocytes and B Lymphomas Express PPAR-γ and Are Killed by PPAR-γ Agonists

Padilla, J., Leung, E., & Phipps, R. P. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5181 · Cited by 121

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

Heneka, M. T., L. Feinstein, D., Galea, E., Gleichmann, M., Wüllner, U., & Klockgether, T. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00192-7 · Cited by 150

Peroxisome Proliferator-Activated Receptor-α Enhances Lipid Metabolism in a Skin Equivalent Model

Rivier, M., Safonova, I., Michel, S., Castiel, I., & Ailhaud, G. P. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00939.x · Cited by 120

PPAR influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis

Nicol, C. J. B. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh160 · Cited by 120

Hepatic over-expression of peroxisome proliferator activated receptor γ2 in the ob/ob mouse model of non‐insulin dependent diabetes mellitus

Rahimian, R., Masih‐Khan, E., Lo, M., van Breemen, C., McManus, B. M., & Dubé, G. P. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1011927113563 · Cited by 120

Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes

Tan, N. S., Michalik, L., Desvergne, B., & Wahli, W. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.025 · Cited by 119

Selective activation of PPARγ in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance

Amin, R., Mathews, S. T., Camp, H. S., Ding, L., & Leff, T. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00446.2009 · Cited by 120

Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease

Belvisi, M. G., & Mitchell, J. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00373.x · Cited by 119

Expression of peroxisome proliferator‐activated receptor (PPAR) in human prostate cancer

Segawa, Y., Yoshimura, R., Hase, T., Nakatani, T., Wada, S., Kawahito, Y., Kishimoto, T., & Sano, H. (2002) · The Prostate · doi:10.1002/pros.10058 · Cited by 117

Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia

Cipolla, M. J., Sweet, J. G., & Chan, S. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01159.2010 · Cited by 117

PPARs Mediate Lipid Signaling in Inflammation and Cancer

Michalik, L., & Wahli, W. (2008) · PPAR Research · doi:10.1155/2008/134059 · Cited by 119

Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance

Guo, L., & Tabrizchi, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.009 · Cited by 117

Artificial Sweeteners: History and New Concepts on Inflammation

Basson, A. R., Rodriguez‐Palacios, A., & Cominelli, F. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.746247 · Cited by 124

Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice

Malloy, V. L., Perrone, C. E., Mattocks, D. A. L., Ables, G. P., Caliendo, N. S., Orentreich, D. S., & Orentreich∥, N. (2013) · Metabolism · doi:10.1016/j.metabol.2013.06.012 · Cited by 118

Reduced Adiposity and Liver Steatosis by Stearoyl-CoA Desaturase Deficiency Are Independent of Peroxisome Proliferator-activated Receptor-α

Miyazaki, M., Dobrzyń, A., Sampath, H., Lee, S., Man, W. C., Chu, K., Peters, J. M., Gonzalez, F. J., & Ntambi, J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405327200 · Cited by 118

The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders

Cullingford, T. E. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.09.008 · Cited by 116

l-arginine uptake, the citrulline–NO cycle and arginase II in the rat brain: an in situ hybridization study

Braissant, O., Gotoh, T., Loup, M., Mori, M., & Bachmann, C. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00151-5 · Cited by 115

Ppars, metabolic disease and atherosclerosis

Fruchart, J., Staels, B., & Duriez, P. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0871 · Cited by 115

Prostaglandin D2 and Its Metabolites Induce Caspase-Dependent Granulocyte Apoptosis That Is Mediated Via Inhibition of IκBα Degradation Using a Peroxisome Proliferator-Activated Receptor-γ-Independent Mechanism

Ward, C., Dransfield, I., Murray, J., Farrow, S. N., Haslett, C., & Rossi, A. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6232 · Cited by 115

Peroxisome Proliferator Activated Receptor

(2006) · Springer eBooks · doi:10.1007/3-540-29719-0_1236

Printed in U.S.A. Copyright © 1998 by The Endocrine Society Differential Expression of Peroxisome Proliferator- Activated Receptor-�,-�, and- � during Rat

Development, E., Braissant, O., & Wahli, W. (2013)

Differential Expression of Peroxisome Proliferator-Activated Receptor- , - , and - during Rat Embryonic Development

Braissant, O., & Wahli, W. (1998) · Endocrinology · doi:10.1210/endo.139.6.6049 · Cited by 457

Prostaglandin and PPAR control of immune cell function

Rotondo, D., & Davidson, J. (2002) · Immunology · doi:10.1046/j.0019-2805.2001.01361.x · Cited by 20

The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation

Schoonjans, K., Staels, B., & Auwerx, J. H. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00066-5 · Cited by 1,045